A shadow economy for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Experimental Treatment Acquiring Traction Via Social Media
The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged fat-burning properties. Viewers are urged to message these profiles privately for supplier links, while also receiving discount codes.
Active Trade on Messaging Platforms
Separately, a robust trade exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors promote the drug there before redirecting customers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Healthcare Experts Express Worries
However, doctors and chemists have cautions that the distribution of what remains an unapproved medication in the United Kingdom is worrisome and could lead to users administering substances of uncertain source.
Some professionals said the demand for retatrutide could be linked to the rising cost of licensed slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Marketing retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate pharmaceutical, advertising, and customer regulations, risking penalties, prosecution or imprisonment.
Service Response and Material Removal
Based on TikTok, the service has taken down violative material and prohibited associated keywords and search suggestions. The organization stated it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.
Digital Marketplace Activities
Investigations also found groups with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, filled with images of slimming results, positive testimonials and detailed guides for mixing or injecting at home.
Within minutes of joining one group, a vendor posted WhatsApp details, where most transactions occur. The vendor provided an guidebook and promised shipping within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None inquired about weight, health issues or previous experience.
Item Details and Pricing
Inside these groups, messages display black plastic packages with Royal Mail stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at home with sterile water, or pre-filled pens typically priced at £160 for 20 milligrams. When asked how long a injector should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Security Measures
A spokesperson for Telegram stated it regularly moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting substances they can’t verify. Even if the research behind retatrutide is valid, these digital versions may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the surge in interest to recent cost increases for approved slimming medications such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.
Her staff has previously seen patients harmed by self-injection from unverified sources. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” said the doctor. “These substances could be impure or improperly measured.”
Producer Statement
A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly investigational product not yet approved … may expose users to possibly significant medical dangers”.
